These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

368 related items for PubMed ID: 2562908

  • 1. Effects of the tumour promoter okadaic acid on intracellular protein phosphorylation and metabolism.
    Haystead TA, Sim AT, Carling D, Honnor RC, Tsukitani Y, Cohen P, Hardie DG.
    Nature; 1989 Jan 05; 337(6202):78-81. PubMed ID: 2562908
    [Abstract] [Full Text] [Related]

  • 2. Activation of peripheral large granular lymphocytes with the serine/threonine phosphatase inhibitor, okadaic acid.
    McVicar DW, Mason AT, Bere EW, Ortaldo JR.
    Eur J Immunol; 1994 Jan 05; 24(1):165-70. PubMed ID: 8020552
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Okadaic acid stimulates IGF-II receptor translocation and inhibits insulin action in adipocytes.
    Tanti JF, Grémeaux T, Cormont M, Van Obberghen E, Le Marchand-Brustel Y.
    Am J Physiol; 1993 Jun 05; 264(6 Pt 1):E868-73. PubMed ID: 8392806
    [Abstract] [Full Text] [Related]

  • 7. Stimulation of glucose transport and glucose transporter phosphorylation by okadaic acid in rat adipocytes.
    Lawrence JC, Hiken JF, James DE.
    J Biol Chem; 1990 Nov 15; 265(32):19768-76. PubMed ID: 2174052
    [Abstract] [Full Text] [Related]

  • 8. Tyrosine dephosphorylation of pp60c-src is stimulated by a serine/threonine phosphatase inhibitor.
    Chackalaparampil I, Bagrodia S, Shalloway D.
    Oncogene; 1994 Jul 15; 9(7):1947-55. PubMed ID: 7516061
    [Abstract] [Full Text] [Related]

  • 9. Involvement of synthesis and phosphorylation of nuclear protein factors that bind to the positive cis-acting element in the transcriptional activation of the CYP2B1/B2 gene by phenobarbitone in vivo.
    Nirodi CS, Sultana S, Ram N, Prabhu L, Padmanaban G.
    Arch Biochem Biophys; 1996 Jul 01; 331(1):79-86. PubMed ID: 8660686
    [Abstract] [Full Text] [Related]

  • 10. Inhibition of histone H1 kinase expression, retinoblastoma protein phosphorylation, and cell proliferation by the phosphatase inhibitor okadaic acid.
    Schönthal A, Feramisco JR.
    Oncogene; 1993 Feb 01; 8(2):433-41. PubMed ID: 8381221
    [Abstract] [Full Text] [Related]

  • 11. Okadaic acid inhibits alkaline phosphatase activity in MC3T3-E1 cells.
    Choi JY, Ryoo HM, Lee BH, Kim HJ, Sohn KY, Jo JS.
    Biochem Mol Biol Int; 1995 Nov 01; 37(5):943-7. PubMed ID: 8624501
    [Abstract] [Full Text] [Related]

  • 12. Effects of protein phosphatase inhibitors on the regulation of insulin-sensitive enzymes within rat epididymal fat-pads and cells.
    Rutter GA, Borthwick AC, Denton RM.
    Biochem J; 1991 Jun 15; 276 ( Pt 3)(Pt 3):649-54. PubMed ID: 1676587
    [Abstract] [Full Text] [Related]

  • 13. Hyperphosphorylation of retinoblastoma protein and p53 by okadaic acid, a tumor promoter.
    Yatsunami J, Komori A, Ohta T, Suganuma M, Fujiki H.
    Cancer Res; 1993 Jan 15; 53(2):239-41. PubMed ID: 8417815
    [Abstract] [Full Text] [Related]

  • 14. Effects of protein phosphatase inhibition by okadaic acid on the differentiation of F9 embryonal carcinoma cells.
    Nishina Y, Sumi T, Iwai SA, Nishimune Y.
    Exp Cell Res; 1995 Apr 15; 217(2):288-93. PubMed ID: 7698228
    [Abstract] [Full Text] [Related]

  • 15. The use of okadaic acid to elucidate the intracellular role(s) of protein phosphatase 2A: lessons from the mast cell model system.
    Boudreau RT, Hoskin DW.
    Int Immunopharmacol; 2005 Sep 15; 5(10):1507-18. PubMed ID: 16023602
    [Abstract] [Full Text] [Related]

  • 16. Effect of okadaic acid in rat adipocytes: differential stimulation of glucose and lipid metabolism and induction of refractoriness to insulin and vanadate.
    Shisheva A, Shechter Y.
    Endocrinology; 1991 Nov 15; 129(5):2279-88. PubMed ID: 1657568
    [Abstract] [Full Text] [Related]

  • 17. Effects of okadaic acid, an inhibitor of protein phosphatases-1 and -2A, on glucose transport and metabolism in skeletal muscle.
    Tanti JF, Grémeaux T, Van Obberghen E, Le Marchand-Brustel Y.
    J Biol Chem; 1991 Feb 05; 266(4):2099-103. PubMed ID: 1846612
    [Abstract] [Full Text] [Related]

  • 18. Protein phosphatase 2A interacts with the Src kinase substrate p130(CAS).
    Yokoyama N, Miller WT.
    Oncogene; 2001 Sep 20; 20(42):6057-65. PubMed ID: 11593413
    [Abstract] [Full Text] [Related]

  • 19. Multiple signal transduction pathways mediate c-Jun protein phosphorylation.
    Franklin CC, Unlap T, Adler V, Kraft AS.
    Cell Growth Differ; 1993 May 20; 4(5):377-85. PubMed ID: 8390855
    [Abstract] [Full Text] [Related]

  • 20. Okadaic acid increases the phosphorylation state of alpha1A-adrenoceptors and induces receptor desensitization.
    Alcántara-Hernández R, García-Sáinz JA.
    Eur J Pharmacol; 2005 Nov 21; 525(1-3):18-23. PubMed ID: 16297906
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.